CLINICAL_TRIALS
trial_result
· 2025-10-24
Clinical Trial Update: Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients [Phase 3]
Summary
A Phase 3 study evaluating a melanoma vaccine in stage IIb, IIc, and III melanoma has been terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Polynoma LLC | Conditions: Melanoma | Phase 3 | Status: TERMINATED | Results posted: 2025-10-24